Publicaciones en colaboración con investigadores/as de Complejo Hospitalario de Toledo (32)

2024

  1. Correction to: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA (Scientific Reports, (2022), 12, 1, (13057), 10.1038/s41598-022-17271-3)

    Scientific Reports

2022

  1. Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Analysis of Global Oxidative Status Using Multimarker Scores Reveals a Specific Association Between Renal Dysfunction and Diuretic Therapy in Older Adults

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 76, Núm. 7, pp. 1198-1205

  2. Cardiovascular Risk Stratification Based on Oxidative Stress for Early Detection of Pathology

    Antioxidants and Redox Signaling, Vol. 35, Núm. 8, pp. 602-617

2020

  1. Novel molecular plasma signatures on cardiovascular disease can stratify patients throughout life

    Journal of Proteomics, Vol. 222

  2. Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations

    Journal of Molecular Medicine, Vol. 98, Núm. 11, pp. 1603-1613

2019

  1. Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: Phase III clinical trial

    BMJ Open Ophthalmology, Vol. 4, Núm. 1

2018

  1. A comprehensive study of calcific aortic stenosis: From rabbit to human samples

    DMM Disease Models and Mechanisms, Vol. 11, Núm. 6

  2. Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Erratum to: KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery (Metabolomics, (2015), 11, (1056-1067), 10.1007/s11306-014-0761-8)

    Metabolomics

  2. Patients with calcific aortic stenosis exhibit systemic molecular evidence of ischemia, enhanced coagulation, oxidative stress and impaired cholesterol transport

    International Journal of Cardiology, Vol. 225, pp. 99-106

2015

  1. KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery

    Metabolomics, Vol. 11, Núm. 5, pp. 1056-1067

  2. Lipid and protein maps defining arterial layers in atherosclerotic aorta

    Data in Brief

  3. Molecular anatomy of ascending aorta in atherosclerosis by MS Imaging: Specific lipid and protein patterns reflect pathology

    Journal of Proteomics, Vol. 126, pp. 245-251

  4. Prediction of development and maintenance of high albuminuria during chronic renin-angiotensin suppression by plasma proteomics

    International Journal of Cardiology, Vol. 196, pp. 170-177

2014

  1. Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome

    Metabolomics, Vol. 10, Núm. 3, pp. 414-424

2013

  1. Deregulation of smooth muscle cell cytoskeleton within the human atherosclerotic coronary media layer

    Journal of Proteomics, Vol. 82, pp. 155-165

  2. Gene expression changes associated with erlotinib response in glioma cell lines

    European Journal of Cancer, Vol. 49, Núm. 7, pp. 1641-1653

  3. Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosis

    Molecular and Cellular Proteomics, Vol. 12, Núm. 9, pp. 2426-2439

2012

  1. Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing

    PLoS ONE, Vol. 7, Núm. 1